ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BioDelivery Sciences to Acquire U.S. and Canadian Rights to ELYXYB™ for Migraine Treatment
August 05, 2021BioDelivery Sciences International Inc., a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, announced that it entered into an agreement on August 3, 2021 with Dr. Reddy’s Laboratories ... -
FDA approves Dr Reddy’s NDA for migraine drug
May 07, 2020The company is working to commercialise Elyxyb (previously known as DFN-15), which is indicated for the acute treatment of migraine with or without aura in adults.
Pharma Sources Insight January 2025
